Back to results
TerminatedPhase 3

Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF

NCT03043651

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Alabama at Birmingham

Birmingham, Alabama, United States

+81 additional locations

View on ClinicalTrials.gov